Nanavaty Maulik

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$990.00
Insider Sells Quantity
22
Insider Sells Sum
$24.42M

Insider Activity of Nanavaty Maulik

According to the SEC Form 4 filings, Nanavaty Maulik, being in a position of

  1. director at Rani Therapeutics Holdings, Inc.,
    оver the last 12 months, has bought 500 shares for $990, and sold 0 shares,
    over all time since 2023-11-16, has bought 500 shares for $990, and sold 0 shares.

The largest purchase of all time was on 2023-11-16 and amounted to 500 shares of Rani Therapeutics Holdings, Inc. for $990.

The largest sale of all time was on 2021-05-28 and amounted to 156384 shares of Boston Scientific Corporation for $6.66M.

Biography of Nanavaty Maulik

No biography is available at this moment.

2023-11-16PurchaseRani Therapeutics Holdings, Inc.
RANI
director
500
0.0009%
$1.98$990+66.5%
2021-05-28SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
156,384
0.011%
$42.59$6.66M+1.61%
2020-08-28SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
76,000
0.0052%
$40.45$3.07M-4.14%
2020-03-02SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
33,526
0.0023%
$37.47$1.26M-3.85%
2020-02-03SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
19,246
0.001%
$29.24$562,753-12.83%
2020-01-03SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
10,050
0.0007%
$44.73$449,513-16.99%
2020-01-02SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
19,246
0.0014%
$45.33$872,429-17.57%
2019-12-04SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
19,246
0.0009%
$27.98$538,581-12.16%
2019-11-27SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
41,104
0.0021%
$30.27$1.24M-12.09%
2019-11-04SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
19,246
0.0009%
$27.37$526,763-6.22%
2019-10-03SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
19,246
0.0009%
$26.17$503,613-2.99%
2019-08-29SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
68,070
0.0029%
$25.02$1.7M-9.02%
2019-06-17SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
6,078
0.0003%
$23.93$145,477+2.78%
2019-05-15SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
6,076
0.0003%
$22.07$134,128+12.79%
2019-04-15SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
6,078
0.0003%
$22.61$137,424+10.63%
2019-03-15SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
6,076
0.0003%
$23.76$144,366+4.08%
2019-02-15SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
6,078
0.0004%
$40.32$245,065+4.27%
2019-01-15SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
6,076
0.0003%
$21.43$130,239+11.04%
2018-11-16SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
46,916
0.0021%
$22.79$1.07M+6.41%
2018-02-09SaleBoston Scientific Corporation
BSX
SVP & Pres, Neuromodulation
31,136
0.0017%
$18.95$590,024+30.32%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.